Posted inWire
Natera to buy Foresight Diagnostics in $450 million oncology tech deal
AUSTIN - Natera Inc has acquired Foresight Diagnostics, a move that expands its portfolio of tests that detect trace amounts of cancer left after treatment, in a deal worth up…